Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans
James Pritchett,
Emma Harvey,
Varinder Athwal,
Andrew Berry,
Cliff Rowe,
Fiona Oakley,
Anna Moles,
Derek A. Mann,
Nicoletta Bobola,
Andrew D. Sharrocks,
Brian J. Thomson,
Abed M. Zaitoun,
William L. Irving,
Indra N. Guha,
Neil A. Hanley,
Karen Piper Hanley September 2012